SRC and sexually transmitted disease: The combinations with stronger binding interactions were AKT1 and luteolin, AKT1 and quercetin, and SRC and quercetin, with −9.9, −9.8, and −9.2 kcal/mol, respectively, indicating that these active components have strong binding affinity for their targets and may play an important role in the treatment of VD by GBLs.